Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

MEA115575: A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of Mepolizumab Adjunctive Therapy to Reduce Steroid Use in Subjects with Severe Refractory Asthma
mepolizumab
MEA115575
NCT01691508
Asthma
Phase 3
 
A follow-on study MEA115661 was conducted. This study is available in CDISC format
November 2015

Powered by ideaPoint, Inc.